Dianyx Innovations

What the Company Does

Dianyx Innovations operates at the intersection of medical devices and artificial intelligence. The company's technology is designed to embed "smart" sensors into oral appliances, which are custom-made devices worn in the mouth to treat snoring and sleep apnea. The traditional limitation of OAT has been the inability to provide continuous, real-time data on treatment efficacy. Dianyx Innovations solves this by introducing a non-invasive, sensor-based technology that monitors a patient?s physiological responses throughout the night. This innovation transforms the oral appliance from a passive device into an active data-gathering tool. The company's work is driven by a focus on providing both patients and healthcare providers with actionable information to improve health outcomes and reduce the shared burden of sleep apnea.

Products and Services

The primary product and service offering from Dianyx Innovations is a system built around its proprietary sensor technology.

• t.e.s.a. (Therapeutic Efficacy Smart Appliance): The central product is an AI-powered sensor, referred to as t.e.s.a., that can be seamlessly embedded into existing and newly fabricated oral appliances. This sensor collects continuous and personalized data on sleep quality, respiratory events, and the effectiveness of the oral appliance. This information is a game-changer for providers, as it enables them to make data-backed adjustments to the device and treatment plan. For the patient, it provides confidence in the efficacy of their treatment.
• Remote Physiological Monitoring (RPM): A key service component of the Dianyx system is the enablement of remote physiological monitoring. The data streamed from the t.e.s.a. sensor can be used by medical prescribers to remotely track a patient?s progress. This not only improves patient care by allowing for timely interventions but also creates a new and consistent revenue stream for healthcare providers through reimbursable RPM services, much like the business model associated with CPAP therapy.
• Partnerships and Market Penetration: Dianyx Innovations places a strong emphasis on strategic partnerships to drive its technology forward. The company collaborates with various stakeholders, including sleep clinics, telehealth companies, and transportation companies, to increase patient access to OAT. By providing a data-driven solution, the company aims to unite the fields of dentistry and medicine, which have historically been separate in the treatment of sleep apnea.
• Concussion Monitoring: In addition to sleep apnea, Dianyx Innovations is also developing its technology for other applications. The same AI-driven sensor technology is being explored for use in concussion monitoring, which demonstrates the versatility and potential of their core intellectual property. This expansion into other areas of medical technology shows the company's long-term vision beyond its initial market focus.

Dianyx Innovations? approach is to provide a subtle, comfortable, and highly effective alternative to traditional sleep apnea treatments. By making OAT a data-rich therapy, it seeks to improve patient compliance, drive better health outcomes, and create a more integrated and profitable ecosystem for the providers who manage this chronic condition.